EW Edwards Lifesciences Corporation

87.23USD+2.44%Mkt Cap: 50.23B $P/E: 51.92

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement prod…

Key Statistics

Company
Market Cap50.23B USD
Enterprise Value45.64B USD
Revenue (TTM)6.51B USD
Gross Profit4.73B USD
Net Income (TTM)1.07B USD
Revenue/Share11.22 USD
Last Price87.23 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees16.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)51.92
P/E (Forward)25.21
PEG1.82
EV/EBITDA22.86
EV/Revenue7.01
P/S7.53
P/B4.62
EPS (TTM)1.68
EPS (Forward)3.38
52W Range
72.3062% of range96.29
52W High96.29 USD
52W Low72.30 USD
Profitability
Gross Margin78.01%
Oper. Margin29.84%
EBITDA Margin30.66%
Profit Margin17.69%
ROE10.38%
ROA7.84%
Growth
Revenue Growth13.60%
Earnings Growth-25.40%
Cash Flow & Leverage
Operating CF1.60B USD
CapEx (TTM)260.20M USD
FCF Margin18.92%
FCF Yield2.45%
Net Debt-3.55B USD
Net Debt/EBITDA-1.78
Balance Sheet
Debt/Equity0.07
Current Ratio4.52
Quick Ratio3.45
Book Value/Sh18.41 USD
Cash/Share7.38 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3:1
Split DateJun 1, 2020
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)100.96 USD
Upside (mean)+15.7%
Target Range84.00 USD – 110.00 USD
84.00+15.7% to mean110.00
# Analysts26
Ownership
Shares Out.575.80M
Float574.49M
Insiders0.19%
Institutions95.61%
Short Interest
Short Ratio3.2d
Short % Float1.79%
Short % Out.1.58%
Shares Short9.09M
Short (prev mo.)10.24M
Technical
SMA 5088.48 (-1.4%)
SMA 20085.13 (+2.5%)
Beta0.85
S&P 52W Chg14.58%
Avg Vol (30d)3.19M
Avg Vol (10d)3.50M
Technical Indicators
RSI (14)49.1
MACD-0.6988
MACD Signal-0.6518
MACD Hist.-0.0469
BB Upper89.49 USD
BB Middle86.79 USD
BB Lower84.10 USD
BB Width6.21%
ATR (14)2.088 USD
Vol Ratio (20d)0.92x